Available from Accessed 5 April 2024 Sam AH, Salem V, Ghatei MA (2011) Rimonabant: from RIO to ban
From the beginning of the experiment until 3 h pi , it significantly increased 30-fold and returned to the initial level at the end of the measurement period
Iranian Journal of Public Health, 50(2): 413-414
This review is based on studies that are either small or non-randomized, and have involved multiple different GLP-1RAs
The key context for this comparison is that both compounds are strictly preclinical -- all claims about cognitive effects are based on animal models, and the translation of these findings to human cognition is uncertain
These findings are important because they demonstrate that these medications are not merely weight loss injections, but genuine metabolic therapies with long-term health benefits